Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
BIO|Sync-HUTT
BIO|Sync-HUTT: Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
1 other identifier
observational
20
1 country
2
Brief Summary
The purpose of this study is to explore changes in patients' hemodynamic parameters during the Head-Up Tilt Test ("HUTT") and their timing with respect to onset of the Closed Loop Stimulation (CLS) pacing. This study aims to add knowledge to better understand the mechanisms underlying recurrent syncopal events and optimal pacing programming.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2022
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2023
CompletedFirst Submitted
Initial submission to the registry
September 1, 2023
CompletedFirst Posted
Study publicly available on registry
September 15, 2023
CompletedResults Posted
Study results publicly available
February 3, 2025
CompletedFebruary 3, 2025
October 1, 2024
8 months
September 1, 2023
June 24, 2024
January 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Heart Rate [Bpm] at Specific Time-points During Head-up Tilt Test (HUTT) Examination
Instantaneous measurement of heart rate value at specific time-points/stages during HUTT examination. Changes in Heart rate were investigated across four stages of the HUTT: baseline (Stage 1), pre-syncopal phase (Stage 2), maximum heart rate/pacing rate (Stage 3), and syncope or lowest Systolic Blood Pressure (Stage 4).
From the start to the end of the HUTT examination, assessed up to 45 minutes
Systolic Blood Pressure at Specific Time-points During Head-up Tilt Test (HUTT) Examination
Instantaneous measurement of blood pressure at specific time-points during HUTT examination. Changes in Systolic blood pressure were investigated across four stages of the HUTT: baseline (Stage 1), pre-syncopal phase (Stage 2), maximum heart rate/pacing rate (Stage 3), and syncope or lowest Systolic Blood Pressure (Stage 4).
From the start to the end of the HUTT examination, assessed up to 45 minutes
Stroke Volume [ml] at Specific Time-points During Head-up Tilt Test (HUTT)
Instantaneous measurement of stroke volume at specific time-points during HUTT examination
From the start to the end of the HUTT examination, assessed up to 45 minutes
Peripheral Resistance [Dyn·s/cm5] at Specific Time-points During Head-up Tilt Test (HUTT)
Instantaneous measurement of peripheral resistance at specific time-points during HUTT examination
From the start to the end of the HUTT examination, assessed up to 45 minutes
Time of Maximum Spontaneous Heart Rate
Recording of a specific time-point during HUTT examination. This time was collected as hours:minutes:seconds (e.g. 00:35:34).
From the start to the end of the HUTT examination, assessed up to 45 minutes
Time of Pacing Onset
Recording of a specific time-point during HUTT examination. This time was collected as hours:minutes:seconds (e.g. 00:35:34).
From the start to the end of the HUTT examination, assessed up to 45 minutes
Time of Recovery of Spontaneous Rhythm After Pacing
Recording of a specific time-point during HUTT examination. This time was collected as hours:minutes:seconds (e.g. 00:35:34).
From the start to the end of the HUTT examination, assessed up to 45 minutes
Time of Syncope
Recording of a specific time-point during HUTT examination. This time was collected as hours:minutes:seconds (e.g. 00:35:34).
From the start to the end of the HUTT examination, assessed up to 45 minutes
Time of Tilt-down
Recording of a specific time-point during HUTT examination. This time was collected as hours:minutes:seconds (e.g. 00:35:34).
From the start to the end of the HUTT examination, assessed up to 45 minutes
Duration of the Recovery Phase [Minutes]
Interval from maximum pacing rate to basic rate or spontaneous rhythm
From the start to the end of the HUTT examination, assessed up to 45 minutes
Slope in Heart Rate [Bpm/Minute] During the Recovery Phase
Calculation of the rate of change of heart rate from the time of maximum pacing rate to the time of basic rate or spontaneous rhythm recovery
From the start to the end of the HUTT examination, assessed up to 45 minutes
Slope in Systolic Blood Pressure (mmHg Per Minute) During the Recovery Phase
Calculation of the rate of change of systolic blood pressure from the time of maximum pacing rate to the time of basic rate or spontaneous rhythm recovery
From the start to the end of the HUTT examination, assessed up to 45 minutes
Eligibility Criteria
Patients with reflex syncope and positive cardioinhibitory response to Head-Up Tilt Test (HUTT) who had already participated in the BIOSync study.
You may qualify if:
- Ability to understand the nature of the study.
- Willingness to provide written informed consent.
- Patients undergoing HUTT for monitoring of syncope, therapy adjustment, training or other medical reasons during ordinary follow-up, irrespective of study participation
- Patients who participated in the BIOSync study\*.
You may not qualify if:
- Pregnant or breast feeding women.
- Age less than 40 years.
- Patients who after the BIOSync study participation have developed the following:
- Any indication to pacemaker different from reflex syncope with positive HUTT response; or
- Any classified indication to implantable defibrillator, cardiac resynchronization therapy according to current guidelines; or
- Any cardiac dysfunctions likely leading to loss of consciousness (overt heart failure, ejection fraction \<40%, myocardial infarction, diagnosis of hypertrophic or dilated cardiomyopathy, clinically significant valvular disease, sinus bradycardia \<50 bpm or sinoatrial block, Mobitz I second degree atrioventricular block, Mobitz II second or third degree atrioventricular block, complete bundle-branch block).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ospedale di Bolzano - Azienda Sanitaria dell'Alto Adige
Bolzano, 39100, Italy
Monaldi - AORN dei Colli - Università della Campania "Luigi Vanvitelli"
Napoli, 80131, Italy
Related Publications (1)
Russo V, Tomaino M, Parente E, Comune A, Giacopelli D, Napoli P, Gargaro A, Brignole M. Temporal relationship between haemodynamic changes and activation of closed-loop stimulation during a tilt-induced vasovagal syncope. Europace. 2024 Feb 1;26(2):euae045. doi: 10.1093/europace/euae045.
PMID: 38340330DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Paola Napoli, Clinical Project Manager
- Organization
- BIOTRONIK Italy
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 1, 2023
First Posted
September 15, 2023
Study Start
September 29, 2022
Primary Completion
May 12, 2023
Study Completion
May 12, 2023
Last Updated
February 3, 2025
Results First Posted
February 3, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
Data will be shared on request to the corresponding author with permission of BIOTRONIK SE \& Co. KG.